CHOP Study: Early Peanut Intro Cuts Child Food Allergies

What the CHOP study looked at

Researchers from CHOP examined electronic health records from dozens of U.S. pediatric practices covering more than 120,000 children. They compared diagnosis rates before and after the 2017 NIAID guidance encouraging earlier peanut exposure and reported a 27% decline in peanut allergy diagnoses among children under age 3 and about a 38% drop in IgE-mediated food allergies overall. For the institution summary, see the CHOP news release and media coverage such as the Fox News summary reporting.

How researchers interpret the findings

The team views the changes as evidence that clearer clinical-trial results plus public guidance have altered feeding practices at scale, and that those changes appear to be lowering some food allergy rates. As CHOP’s Stanislaw Gabryszewski, M.D., Ph.D., put it:

“Clinical research, when coupled with clear guidelines… can shift the trajectory of childhood food allergy.”

Note: the study reports an association between uptake of guidance and falling diagnoses; it does not prove causation at the individual-child level.

How this builds on earlier trials and guidance

The shift toward early peanut introduction began with the landmark 2015 LEAP trial, which showed an ~81% reduction in peanut allergy risk for high‑risk infants who consumed peanut between 4 and 11 months. That trial led to the 2017 NIAID guidance recommending earlier peanut exposure for high‑risk infants and later broadened guidance in 2021 to suggest introducing peanut, egg and other common allergens as early as 4–6 months for most infants. Context and summaries are available in the LEAP context and guidelines and the ACAAI summary.

Experts weigh in

Allergy specialists described the CHOP results as meaningful and encouraging. Cherie Zachary, M.D., then‑president of the American College of Allergy, Asthma & Immunology, called the results “very promising,” noting that small, early exposures may help the immune system develop tolerance. See the ACAAI guidance for practical recommendations.

Important caution: experts stress this is observational work—other factors could have influenced diagnosis rates—and the study did not track each child’s feeding practices directly.

Study limitations to keep in mind

• Data source: the analysis relied on electronic health records, which capture diagnosed cases but may miss undiagnosed allergies or care provided outside the participating practices.
• Timeframe: the data end in early 2019, so the study does not quantify effects of the 2021 guidance that expanded recommendations to all infants.
• Study design: observational analysis shows association, not individual-level causation, because it did not record each child’s feeding history.

Trends and practical tips for parents

The CHOP findings align with other signals that early allergen introduction is making a real-world difference. Allergy groups and public-health advocates recommend practical, safe steps:

• Offer small amounts of age‑appropriate peanut product (for example, peanut powder or peanut butter thinned with water or breast milk) around 4–6 months as part of solid-food introduction; see ACAAI guidance.
• Continue peanut-containing foods at least twice weekly during the first year to help build tolerance.
• Never give whole peanuts to young children because of choking risk.
• Parents of infants with severe eczema or existing egg allergy should consult their pediatrician or an allergist before introducing peanut products, consistent with 2017 NIAID guidance and summaries such as the guidance summary.

Other shifts in allergen patterns

As peanut diagnoses fell during the studied period, egg became the most commonly diagnosed allergen in young children, surpassing peanuts. Milk and wheat also remain frequent causes of IgE‑mediated reactions. Coverage and expert summaries include news reports and the ACAAI summary.

Practical barriers and clinician training

Even after guidance changed, many parents remained uncertain about how and when to introduce allergens. Studies show confusion persists and that clinician training tools can improve adherence to guidance. See reporting on parent awareness from Lurie Children’s reporting and evidence that training tools improve provider adherence in the training tools study reporting.

Implications for California

Economic: California’s large birth cohort means even modest drops in childhood food-allergy diagnoses could reduce clinic and emergency visits, testing and medication costs, and ease pressure on Medicaid and private payers. The CHOP findings support arguments that wider adoption of early-feeding guidance could yield measurable public‑health returns; see the National Peanut Board summary.

Policy and social effects: state health agencies and medical societies may use this evidence to strengthen outreach, clinician training and culturally tailored education for diverse communities. Policymakers overseeing Medicaid, WIC and early‑childhood programs could prioritize resources that help parents safely introduce allergens. Clear public messaging is critical given prior advice to avoid peanuts; clinics serving non‑English speakers should offer translated, culturally relevant materials.

Practical applications for California providers and families

• Pediatricians and family physicians should review the NIAID guidance and CHOP findings to advise families based on individual risk and age.
• Public‑health programs can create outreach materials explaining safe peanut introduction and when to refer to specialists.
• Childcare centers and schools should reassess allergy policies and staff training to reflect shifting allergen patterns, including the increased proportion of egg diagnoses.

Reporting and sources

This article draws on the CHOP release and national reporting, plus guidance and commentary from allergy organizations and research summaries:

• CHOP news release
• Fox News summary reporting
• ACAAI summary
• National Peanut Board summary
• Lurie Children’s reporting on parent awareness
• Training tools study reporting
• JAMA Network discussion on parent practices and guidance complexities

Bottom line: the CHOP study strengthens the case that earlier, age‑appropriate peanut introduction is associated with fewer child food allergy diagnoses. Parents in California and elsewhere should discuss timing and method with their pediatrician—especially for infants with eczema or other risk factors—and follow safe-feeding practices such as avoiding whole nuts and offering thinned peanut products.